Table III.
Changes of SCr and eGFR in the two groups
| Time | SCr [mg/dl] | eGFR [ml/min/1.73 m2] | ||
|---|---|---|---|---|
| Treatment group | Controlgroup | Treatment group | Control group | |
| Baseline | 136.8 ±25.5 | 136.1 ±23.7 | 43.4 ±6.1 | 42.8 ±5.9 |
| 1 month | 123.4 ±19.9# | 137.6 ±23.5 | 46.7 ±5.0 | 42.3 ±6.0 |
| 2 months | 120.5 ±21.2*# | 139.8 ±24.5 | 47.9 ±4.8 | 41.9 ±6.0 |
| 3 months | 118.7 ±20.0*# | 141.3 ±25.3 | 49.3 ±4.9 | 41.4 ±5.8 |
| 6 months | 120.6 ±19.6*# | 142.8 ±25.4 | 49.6 ±5.3 | 39.6 ±5.7 |
| 12 months | 122.5 ±20.2*# | 144.0 ±26.3 | 47.1 ±5.0 | 38.2 ±5.5 |
| 18 months | 123.3 ±18.9*# | 145.6 ±26.5 | 46.1 ±5.0 | 37.7 ±5.5 |
| 24 months | 124.0 ±19.0*# | 145.3 ±25.8 | 46.0 ±4.6 | 37.2 ±5.4 |
| 30 months | 124.9 ±19.8*# | 145.8 ±25.8 | 45.8 ±4.7 | 36.2 ±5.2 |
| 36 months | 126.0 ±19.7*# | 146.2 ±26.1 | 45.8 ±4.8 | 35.8 ±5.3 |
| F-value | Ftime 62.78 | Fgroup 52.25 | Fgroup*time 62.87 | p < 0.001 |
Data are presented as mean ± SD. eGFR was calculated using the CKD-EPI equation
*
P < 0.001 vs. control group
#
P < 0.001 vs. baseline.